HIV-gp160 modulates differentially the production in vitro of IgG, IgA and cytokines by blood and tonsil B lymphocytes from HIV-negative individuals

Clinical and Experimental Immunology

Volumn 132, Issue 2, 2003, Pages 304-308

  Cognasse, F ^a   Beniguel L ^a   El Habib, R ^c   Sabido, O ^b   Chavarin, P ^d   Genin, C ^a   Garraud, O ^a,b,d  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ JEAN MONNET   (France)

^c SANOFI PASTEUR   (France)

^d ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Antibodies; B cells; Cytokines; Envelope proteins; HIV

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN GP 160; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; RECOMBINANT GLYCOPROTEIN GP 160; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; EXPERIMENTAL TEST; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; INFLAMMATION; LYMPHOCYTE; PRIORITY JOURNAL; TONSIL; UPREGULATION;

EID: 0038216877     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02152.x     Document Type: Article

References (20)

1. Letvin NL, Barouch DH, Montefiori DC. Prospects for vaccine protection against HIV-1 infection and AIDS. Annu Rev Immunol 2002; 20:73-99.
2. Karray S, Zouali M. Identification of the B cell superantigen-binding site of HIV-1 gp120. Proc Natl Acad Sci USA 1997; 94:1356-60.
3. Becquart P, Hocini H, Garin B, Sepou A, Kazatchkine MD, Belec L. Compartmentalization of the IgG immune response to HIV-1 in breast milk. Aids 1999; 13:1323-31.
4. Devito C, Hinkula J, Kaul R et al. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. Aids 2000; 14:1917-20.
5. Moja P, Tranchat C, Tchou I et al. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients. J Infect Dis 2000; 181:1607-13.
6. Senez B, Laugier J. [Indications for adenoidectomy and/or tonsillectomy in children. Work Group for the National Agency for Health Accreditation and Evaluation (ANAES)]. Ann Otolaryngol Chir Cervicofac 1998; 115 (Suppl. 1):S22-45.
7. + B lymphocytes from Plasmodium falciparum-immune West Africans. Scand J Immunol 2001; 54:606-12.
8. Garraud O, Nkenfou C, Bradley JE, Perler FB, Nutman TB. Identification of recombinant filarial proteins capable of inducing polyclonal and antigen-specific IgE and IgG4 antibodies. J Immunol 1995; 155:1316-25.
9. Seydi A, Nambei WS, Goumabala M et al. In vitro production of immunoglobulins of various classes and subclasses by cord blood B cells in African neonates: modeling and assessment of determination. Immunol Lett 2001; 77:119-24.
10. Ling NR. Immunoglobulin production by cultured human lymphocytes. J Immunol Meth 2000; 238:3-15.
11. Tangye SG, Ferguson A, Avery DT, Ma CS, Hodgkin PD. Isotype switching by human B cells is division-associated and regulated by cytokines. J Immunol 2002; 169:4298-306.
12. Fournier AM, Fondere JM, Alix-Panabieres C et al. Spontaneous secretion of immunoglobulins and anti-HIV-1 antibodies by in vivo activated B lymphocytes from HIV-1-infected subjects: monocyte and natural killer cell requirement for in vitro terminal differentiation into plasma cells. Clin Immunol 2002; 103:98-109.
13. Garraud O, Nutman T. The roles of cytokines on human B cell differentiation into immunoglobulin secreting cells. Bull Inst Pasteur 1993; 94:285-309.
14. Pistoia V. Production of cytokines by human B cells in health and disease. Immunol Today 1997; 18:343-50.
15. Matthes T, Werner-Favre C, Tang H, Zhang X, Kindler V, Zubler RH. Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor alpha, interleukin (IL) 6, IL-10, and transforming growth factor beta 1 mRNAs. J Exp Med 1993; 178:521-8.
16. Pistoia V, Corcione A. Relationships between B cell cytokine production in secondary lymphoid follicles and apoptosis of germinal center B lymphocytes. Stem Cells 1995; 13:487-500.
17. Capobianchi MR. Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis. J Biol Regul Homeost Agents 1996; 10:83-91.
18. Banchereau J, Rousset F, Human B. lymphocytes: phenotype, proliferation and differentiation. Adv Immunol 1992; 52:125-262.
19. Chakrabarti BK, Kong WP, Wu BY et al. Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization. J Virol 2002; 76:5357-68.
20. Scamurra RW, Nelson DB, Lin XM et al. Mucosal plasma cell repertoire during HIV-1 infection. J Immunol 2002; 169:4008-16.